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Abstract 
Within the larger ABC superfamily of ATPases, ABCF family members eEF3 in Saccharomyces 
cerevisiae and EttA in Escherichia coli have been found to function as ribosomal translation factors. 
Several other ABCFs including biochemically characterised VgaA, LsaA and MsrE confer resistance 
to antibiotics that target the peptidyl transferase centre and exit tunnel of the ribosome. However, 
the diversity of ABCF subfamilies, the relationships among subfamilies and the evolution of 
antibiotic resistance factors from other ABCFs have not been explored. To address this, we 
analysed the presence of ABCFs and their domain architectures in 4505 genomes across the tree of 
life. We find 45 distinct subfamilies of ABCFs that are widespread across bacterial and eukaryotic 
phyla, suggesting they were present in the last common ancestor of both. Surprisingly, currently 
known antibiotic resistance (ARE) ABCFs are not confined to a distinct lineage of the ABCF family 
tree, suggesting antibiotic resistance can readily evolve from other ABCF functions. Our data 
suggest there are a number of previously unidentified ARE ABCFs in antibiotic producers and 
important human pathogens. We also find that ATPase-deficient mutants of all four E. coli ABCFs 
(EttA, YbiT, YheS and Uup) inhibit protein synthesis, indicative of their ribosomal function, and 
demonstrate a genetic interaction of ABCFs Uup and YheS with translational GTPase BipA involved 
in assembly of the 50S ribosome subunit. Finally, we show that the ribosome-binding resistance 
factor VmlR from Bacillus subtilis is localised to the cytoplasm, ruling out a role in antibiotic efflux.  
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Introduction 
Protein biosynthesis – translation – is the reading and deciphering of information coded in genes 
to produce proteins. It is one of the most ancient and central cellular processes, and control of the 
various stages of translation is achieved via an intricate interplay of multiple molecular 
interactions. For many years, enzymatic control of the ribosomal cycle was thought to be mainly 
orchestrated mainly by translational GTPases (trGTPases). That view of translation has been 
nuanced by the identification of multiple ATPases in the ABC superfamily that have important 
roles in translational regulation on the ribosome. The ABC protein eEF3 (eukaryotic Elongation 
Factor 3) is an essential factor for polypeptide elongation in Saccharomyces cerevisiae [1] with 
proposed roles in E-site tRNA release and ribosome recycling [2-4]. This fungi-specific 
translational ABC ATPase appeared to be an exception to the tenet that trGTPases are the 
enzymatic rulers of the ribosome, until ABCE1 (also known as Rli1), a highly conserved protein in 
eukaryotes and archaea, was identified as another ribosome recycling factor [5-7].  
 
The ABC ATPases together comprise one of the most ancient superfamilies of proteins, evolving 
well before the last common ancestor of life [8]. The superfamily contains members with wide 
varieties of functions, but is best known for its membrane transporters [9]. Families of proteins 
within the ABC superfamily are named alphabetically ABCA to ABCH, following the nomenclature 
of the human proteins [10]. While most ABCs carry membrane-spanning domains (MSDs), these 
are lacking in ABCE and ABCF families [11]. ABCF proteins of eukaryotes include eEF3, and also 
other ribosome-associated proteins: Gcn20 is involved in sensing starvation by the presence of 
uncharged tRNAs on the eukaryotic ribosome [12]; ABC50 (ABCF1) promotes translation initiation 
in eukaryotes [13]; and both Arb1 (ABCF2) and New1 have been proposed to be involved in 
biogenesis of the eukaryotic ribosome [14, 15]. Ribosome-binding by ABCF proteins seemed to be 
limited to eukaryotes until the characterisation of ABCF member EttA (energy-dependent 
translational throttle A) found in diverse bacteria. Escherichia coli EttA binds to the E-site of the 
ribosome where it is proposed to ‘throttle’ the transition from initiation to the elongation stage of 
translation in response to change in the intercellular ATP/ADP ratio [16, 17]. EttA is one of four E. 
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coli ABCFs, the others being YheS, Uup and YbiT. None of the latter three has yet been shown to 
operate on the ribosome [16].  
 
Bacterial ABCF family members have been found to confer resistance to ribosome-inhibiting 
antibiotics widely used in clinical practise, such as ketolides [18], lincosamides [19-22], macrolides 
[23, 24], oxazolidinones [25], phenicols [25], pleuromutilins [22] and streptogramins A [22, 26] 
and B [24]. These antibiotic resistance (ARE) ABCFs have been identified in antibiotic-resistant 
clinical isolates of Staphylococcus, Streptomyces and Enterococcus among others [27]. This includes 
the so-called ESKAPE pathogens Enterococcus faecium and Staphylococcus aureus that contribute 
to a substantial proportion of hospital-acquired multidrug-resistant infections [28]. As some efflux 
pumps carry the ABC ATPase domain, it was originally thought that ARE ABCFs similarly confer 
resistance by expelling antibiotics. However, as they do not carry the necessary transmembrane 
domains, this is unlikely [29, 30]. In support of this, it was recently shown that Staphylococcus 
aureus ARE VgaA protects protein synthesis activity in cell lysates from antibiotic inhibition and 
that Enterococcus faecalis ARE LsaA promotes the release of radioactive lincomycin from S. aureus 
ribosomes [31]. Using a reconstituted biochemical system, we have shown that VgaA and LsaA 
directly protect the ribosome peptidyl transferase centre (PTC) from antibiotics in an ATP-
dependent manner [32]. Recent cryo-electron microscopy (cryo-EM) structures of AREs 
Pseudomonas aeruginosa MsrE and Bacillus subtilis VmlR on the ribosome show that like EttA, 
these ABCFs bind to the E-site of the ribosome, with extended inter-ABC domain linkers protruding 
into the PTC [33, 34]. The ARE ABCFs therefore appear to either physically interact with the drug 
to displace it from the ribosome, or allosterically induce a change in conformation of the ribosome 
that ultimately leads to drug drop-off [35-37].  
 
Here, we carry out an in-depth survey of the diversity of ABCFs across 4505 species with 
sequenced genomes. We find 45 groups (15 in eukaryotes and 30 in bacteria), including 7 groups 
of AREs. So-called EQ2 mutations, double glutamic acid to glutamine substitutions in the two 
ATPase active sites of EttA, lock the enzyme on the ribosome in an ATP-bound conformation, 
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inhibiting protein synthesis and cellular growth [16, 17]. We have tested the effect of equivalent 
mutations in the other three E. coli ABCFs – YbiT, YheS and Uup – as well as the Bacillus subtilis 
ARE VmlR. We establish genetic associations of E. coli ABCFs YheS and Uup with the translational 
GTPase BipA (also known as TypA), and through microscopy and polysome profile analyses, 
confirm that VmlR does not confer lincomycin resistance through acting as a membrane-bound 
pump, but via direct interaction with cytoplasmic ribosomes. 
 
Results  
ABCFs are widespread among bacteria and eukaryotes 
 
To identify candidate subfamilies of ABCFs and refine the classifications, an iterative bioinformatic 
protocol of sequence searching and phylogenetic analysis was applied. Sequence searching was 
carried out against a local database of 4505 genomes from across the tree of life. For an initial 
overview of the breadth of diversity of ABCFs across life, sequence searching began with a local 
BlastP search against a translated coding sequence database limited by taxonomy to one 
representative per class, or order if there was no listed class for that species in the NCBI taxonomy 
database. From phylogenetic analysis of the hits, preliminary groups were identified and extracted 
to make Hidden Markov Models (HMMs) for further sequence searching and classification. 
Additional sequences from known ARE ABCFs were included in phylogenetic analyses in order to 
identify groups of ARE-like ABCFs. HMM searching was carried out at the genus level followed by 
phylogenetic analysis to refine subfamily identification, with final predictions made at the species 
level. The resulting classification of 16848 homologous sequences comprises 45 subfamilies, 15 in 
eukaryotes and 30 in bacteria. Phylogenetic analysis of representatives across the diversity of 
ABCFs shows a roughly bipartite structure, with most eukaryotic sequences being excluded from 
those of bacteria with strong support (fig. 1). Five eukaryotic groups that fall in the bacterial part 
of the tree are likely to be endosymbiotic in origin (see the section Bacteria-like eukaryotic ABCFs, 
below). 
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ABCFs are widespread among bacteria and eukaryotes; there are on average four ABCFs per 
bacterial genome, and five per eukaryotic genome. However, there is considerable variation in how 
widespread each subfamily is (table 1). The presence of all subfamilies in each genome considered 
here is shown in table S1, with the full set of sequence identifiers and domain composition 
recorded in table S2. Domain coordinates by amino acid position can be found in table S3. Within 
bacteria, Actinobacteria, and Firmicutes are the phyla with the largest numbers of ABCFs (up to 11 
per genome), due to expansions in ARE and potential novel ARE subfamilies. Among eukaryotes, 
plants and algae encode the most subfamilies, probably due in part to gene acquisition from 
endosymbiosis events. The diatom Fragilariopsis cylindrus has 30 ABCFs and the Haptophyte 
Emiliania huxleyi has 26. Bacterial contamination can sometimes inflate the number of genes in 
eukaryotic genomes as noted previously for trGTPases [35]. However, as all the Fragilariopsis and 
Emiliania sequences belong to typically eukaryotic subgroups, they do not appear to be the result 
of bacterial contamination. The Tibetan antelope Pantholops hodgsonii, on the other hand has 25 
ABCFs, 20 of which belong to bacterial subgroups. This genome is known to be contaminated by 
sequences from Bradyrhizobium, a well-known laboratory contaminant [38]. Thus the bacteria-like 
hits from P. hodgsonii are most likely artifacts rather than bona fide cases of horizontal gene 
transfer from bacteria to eukaryote. 
 
The broad distribution and multi-copy nature of ABCFs suggests an importance of these proteins. 
However they are not completely universal, and are absent in almost all Archaea. The 
euryarcheaotes Candidatus Methanomassiliicoccus intestinalis, Methanomethylophilus alvus, 
Methanomassiliicoccus luminyensis, and Thermoplasmatales archaeon BRNA1 are the only archaeal 
genomes in which we identified ABCFs, in each case YdiF. However, with more archaeal genomes 
being completed, the complement of ABCFs found in isolated lineages of this domain of life is likely 
to increase. ABCFs are lacking in 214 bacterial species from various phyla, including many 
endosymbionts. However, the only phylum that is totally lacking ABCFs is Aquificae. ABCFs are 
almost universal in Eukaryotes; the only genomes where they were not detected are those of 
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Basidomycete Postia placenta, Microsporidium Enterocytozoon bieneusi, and apicomplexan genera 
Theileria, Babesia and Eimeria.  
 
Many of the phylogenetic relationships among subfamilies of ABCFs are poorly resolved (fig. 1). 
This is not surprising, since these represent very deep bacterial relationships that predate the 
diversification of major phyla and include gene duplication, and differential diversification and 
loss, and likely combine both vertical inheritance and horizontal gene transfer. Although 
relationships can not be resolved among all subfamilies, some deep relationships do have strong 
support (that is, maximum likelihood bootstrap percentage (MLB) of more than 85%, ultrafast 
bootstrap (UFB) support of over 90%, and Bayesian inference posterior probability (BIPP) of 1.0); 
EttA and Uup share a common ancestor to the exclusion of other ABCFs with full support (100% 
MLB, 100% UFB and 1.0 BIPP fig. 1, fig. S1) and YheS is the closest bacterial group to the 
eukaryotic ABCFs with strong support (94% MLB, 98% UFB, and 1.0 BIPP; (fig. 1, fig. S1, text S1). 
This latter observation suggests that eukaryotic-like ABCFs evolved from within the diversity of 
bacterial ABCFs. However, this depends on the root of the ABCF family tree. To address this, 
phylogenetic analysis was carried out of all ABCFs from E. coli, Homo sapiens, S. cerevisiae and B. 
subtilis, along with ABCE family sequences from the UniProt database [39]. Rooting with ABCE 
does not provide statistical support for a particular group at the base of the tree, but does support 
the eukaryotic subgroups being nested within bacteria, with YheS as the closest bacterial group to 
the eukaryotic types (fig. 2). It also shows that eEF3 and New1 are nested within the rest of the 
ABCF family, thus confirming their identity as ABCFs, despite their unusual domain structure. To 
address the possibility that due to recombination the two ABC domains of the ABCF family may 
have had different evolutionary histories, we repeated our phylogenetic analysis of representative 
sequences with the ABC domains uncoupled and aligned to each other (fig. 1, Text S1). With this 
very short alignment (204 positions) containing a larger proportion of almost invariant active site 
residues, there is even less statistical support for relationships among subgroups. Nevertheless, we 
still retain the branches that are well supported in our full-length analyses (fig. 1), and thus there is 
no evidence for recombination.  
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Domain architectures in the ABCF family are variable 
 
To assess the conservation of domains across the family tree of ABCFs, we extracted the domain 
regions from subfamily alignments, made HMMs representing each domain region and scanned 
every sequence in our database. We find the most common domain and subdomain arrangement is 
an N-terminal ABC1 nucleotide binding domain (NBD) containing an internal Arm subdomain (the 
L1-interacting region first reported for EttA [16, 17]), followed by the Linker region joining to the 
ABC2 NBD (fig. 3A).  The inter-domain Linker (as it is referred to for VgaA [40] and MsrE [33]) 
corresponds to the structural region referred to as the P-site tRNA interaction motif, PtIM for EttA 
[16, 17], and the antibiotic resistance domain (ARD) for VmlR [34]. Variations on this basic 
structure include deletions in the Arm and Linker regions, insertion of a Chromo (chromatin 
organisation modifier) subdomain in the ABC2 NBD, and extension of N and C termini by sequence 
extensions (fig. 3A). The domain structures of eukaryotic ABCFs are more diverse than those of 
bacteria, with greater capacity for extensions of the N-terminal regions to create new domains (fig. 
3A). An increased propensity to evolve extensions, especially at the N terminus is also seen with 
eukaryotic members of the trGTPase family [35]. In bacteria, terminal extensions of ABCFs tend to 
be at the C terminus (fig. 3A-B).  
 
Cryo-electron microscopy structures show that bacterial ABCFs bind to the same site of the 
ribosome, which is different from that of eEF3 [2, 17, 33, 34], and this is reflected in their domain 
architectures. eEF3 carries additional N-terminal domains and does not have the Arm subdomain 
that in EttA binds the L1 stalk and ribosomal protein L1. Instead it carries a Chromo subdomain in 
the ABC2 NBD that – from a different orientation to the Arm domain of EttA - interacts with, and 
stabilises the conformation of the L1 stalk [2]. The Arm subdomain is also missing in eEF3-like 
close relatives New1 and eEF3L. Although the Arm is widespread in bacterial ABCFs, it is not 
universal; it is greatly reduced in a number of subfamilies, with the most drastic loss seen in ARE1 
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and 2 (figs. 3A, and see Putative AREs section, below). Subdomain composition can even vary 
within subfamilies; Uup has lost its arm independently in multiple lineages (fig. 1, fig. S1). 
 
Arms, Linkers and CTD extensions are poorly conserved at the primary sequence level, but are 
similar in terms of composition, all being rich in charged amino acids, particularly arginine and 
lysine. Their variable presence and length suggests they can be readily extended or reduced during 
evolution. The CTD of Uup forms a coiled coil structure that is capable of binding DNA [41]. 
However, whether DNA binding is its primary function is unclear. The CTD of YheS has significant 
sequence similarity (E value 3.58e-03) to the tRNA binding CTD of Valine-tRNA synthetase (NCBI 
conserved domains database accession cl11104). In silico coiled coil prediction suggests there is a 
propensity of all these regions to form coiled coil structures (fig. 3B). Extensions and truncations of 
the Arms, Linkers and CTD extensions possibly modulate the length of coiled coil protrusions that 
extend from the globular mass of the protein.   
 
Eukaryotic ABCFs comprise 15 subfamilies 
 
eEF3, New1 and eEF3L 
eEF3, eEF3L and New1 group together and are particularly distinct members of the ABCF family. 
The eEF3 subfamily represents the classical fungal proteins, while eEF3L is a more divergent group 
found mainly in protists (see below). eEF3 has a recent paralogue in S. cerevisiae (Hef3 (fig. 2), 
YEF3B) that apparently arose as a result of the whole genome duplication in yeast [42, 43]. The 
conservation of domain structure in eEF3/New1/eEF3L suggests they bind the ribosome similarly 
(fig. 3A). Ribosome binding by eEF3 involves the Chromo subdomain, and the HEAT (Huntington, 
EF3, A subunit of PP2A, TOR1) domain [2], which in addition to New1 and eEF3L, is also found in 
the protein Gcn1, a binding partner of the ABCF Gcn20 [44] (see the section ABCF1-7, below). eEF3 
has a distinct C-terminal extension (fig. 3A), through which it interacts with eEF1A [45]. It has been 
suggested that this leads to the recruitment of eEF1A to S. cerevisiae ribosomes [45, 46]. The New1 
CTD contains a region of sequence similarity to the eEF3 CTD; both contain a polylysine/arginine-
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rich tract of 20-25 amino acids (fig. S2). In S. cerevisiae eEF3, this is at positions 1009-1031, which 
falls within the eEF1A-binding site. Thus eEF1A binding may be a common feature of eEF3, New1, 
and also eEF3L, which commonly includes an eEF3-like C-terminal extension (table S2). 
 
We find eEF3-like (eEF3L) factors in a range of eukaryotes including choanoflagellates, 
haptophytes, heterokonts, dinoflagellates, cryptophytes and red and green algae. This suggests the 
progenitor of eEF3 was an ancient protein within eukaryotes, and has been lost in a number of 
taxonomic lineages. Alternatively, eEF3L may have been horizontally transferred in eukaryotes. 
eEF3 is found in Chlorella viruses [47] and Phaeocystis viruses (fig. S3), suggesting this may be a 
medium of transfer. There is no “smoking gun” for viral-mediated transfer in the phylogenies, in 
that eukaryotic eEF3L sequences do not nest within viral sequence clades (fig. S3). However, given 
the close association of viral and protist eEF3L, this still remains a possibility. Curiously, the 
taxonomic distribution of eEF3L in available genomes of diverse and distantly related protists is 
similar (although not identical) to that of the unusual elongation factor 1 (eEF1A) paralogue EFL 
[48] (table S4). The propensity for eEF3/eEF3L/New1 to be present in EFL-encoding organisms 
and absent in eEF1A-encoding organisms is significant at the level of P<0.0001 with Fisher’s exact 
test. Yeasts are an exception to this tendency, in that they carry eEF1A and eEF3. Like eEF3L, EFL 
can be found in viruses such as Aureococcus anophagefferens virus (NCBI protein accession 
YP_009052194.1). As eEF3 interacts with eEF1A [46], the equivalents eEF3L and EFL may also 
interact in the organisms that encode them.  
 
Like eEF3, New1 is found across the fungal tree of life (table S1, fig. S3). S. cerevisiae New1 has 
previously been reported to carry a prion-like Y/N/Q/G repetitive region in the N-terminal domain 
before the HEAT domain [49]. We find that this region is limited in taxonomic distribution to 
Saccharomycetale yeast (table S2, fig. 3A and fig. S2). Thus it is not found in the N-terminal region 
of Schizosaccharomyces pombe New1 (also known as Elf1).  
 
ABCF1-7 
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ABCF1-7 comprise the “ancestral-type” eukaryotic ABCFs, in that they have the typical ABC domain 
structure that is seen in bacterial ABCFs, and they lack the Chromo and HEAT domains that are 
found in eEF3, New1 and eEF3L (fig. 3A). All of the terminal extensions found in ABCF subfamilies 
are biased towards charged amino acids, often present as repeated motifs. The ABCF1 (ABC50) 
NTD (which interacts with eIF2 [50]) is, due to its length and number of repeats, one of the most 
striking (fig. S2). It contains multiple tracts of poly-lysine/arginine, poly–glutamic acid/aspartic 
acid and – in animals - poly-glutamine. ABCF1 and ABCF2 have moderate support as sister groups 
(fig. 1), and both have representatives in all eukaryotic superphyla, but are not universal. Lineages 
that have notable absences of ABCF1 are fungi, amoebozoa and most Aves (birds) (table 1, table 
S1). Schizosaccharomycetes carry a divergent ABCF1 NTD domain-containing protein (ABCF1/2) 
that associates phylogenetically with ABCF2 (figs S1 and S3). 
 
ABCF2 (Arb1) is essential in yeast and its disruption leads to abnormal ribosome assembly [14]. 
Human ABCF2 can complement an Arb1 deletion, suggesting conservation of function [51]. The 
protein is broadly distributed across eukaryotes, with the notable exception of the Alveolata 
superphylum (Table S1). Like other ABCF terminal extensions, the ABCF2 N-terminal domain is 
rich in lysine, in this case lysine and alanine repeats. 
 
In yeast, where it is known as Gcn20, ABCF3 is a component of the general amino acid control 
(GAAC) response to amino acid starvation, acting in a complex with Gcn1 [52]. Gcn20 binds to 
Gcn1 via the latter’s HEAT-containing N-terminal domain [44], an interaction that is conserved in 
ABCF3 and Gcn1 of Caenorhabditis elegans [53]. As the HEAT domain is also found in eEF3, this 
raises the possibility that Gcn20/ABCF3 and eEF3 interact in encoding organisms (fig. 3A). 
Possible support for this comes from the observation that eEF3 overexpression impairs Gcn2 
activation [54].  
 
ABCF3 is widespread in eukaryotes, but absent in heterkont algae and archaeplastida. However, 
these taxa encode ABCF4 and ABCF7 of unknown function, which have N-terminal domains 
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homologous to ABCF3. Thus, ABCF4 and ABCF7 may be the functional equivalents of ABCF3 in 
these taxa, potentially interacting with HEAT domain-containing eEF3L in organisms that encode 
the latter (fig. 3A). ABCF3 from four fungi (Setosphaeria turcica, NCBI protein accession number 
XP_008030281.1; Cochliobolus sativus, XP_007703000.1; Bipolaris oryzae, XP_007692076.1; 
and Pyrenophora teres, XP_003306113.1) are fused to a protein with sequence similarity to WHI2, 
an activator of the yeast general stress response [55]. 
 
ABCF5 is a monophyletic subfamily limited to fungi and green algae (Volvox and Chlamydomonas), 
with a specific NTD and CTD (fig. 1 and 2A). ABCF5 is found in a variety of Ascomycete and 
Basidiomycete fungi, including the yeast Debaryomyces hansenii, but is absent in yeasts S. pombe 
and S. cerevisiae. ABCF4 is a polyphyletic group of proteins found in various algal and amoeba 
protists that can not be assigned to the ABCF5, or eEF3/eEF3L/New1 clades. In eukaryotic ABCF-
specific phylogenetic analysis, ABCF4/ABCF5/eEF3/eEF3L/New1 are separated from all other 
eukaryotic ABCFs with moderate support (85% MLB fig. S3). ABCF6 represents a collection of algal 
and amoebal sequences that associate with the ABCF1+ABCF2 clade with mixed support in 
phylogenetic analysis (fig. 1). 
 
Bacterial-like eukaryotic ABCFs 
Five eukaryotic subfamilies are found in the bacteria-like subtree: algAF1, algUup, mEttA, algEttA 
and cpYdiF (fig. 1). Given their affiliation with bacterial groups, they may have entered the cell with 
an endosymbiotic ancestor. Indeed, chloroplast-targeting peptides are predicted at the N termini of 
the majority of cpYdiF sequences, and mitochondrial localization peptides at most mEttA N 
termini. The situation is less clear for the three remaining groups, with a mix of signal peptides, or 
none at all being predicted across the group members (table S5). 
 
Bacterial ABCFs comprise 30 subfamilies, most of which have unknown function  
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 13 
There are 30 groups of bacterial ABCFs, the most broadly distributed being YdiF (the subfamily is 
given the name of the Bacillus subtilis protein as it is not present in E. coli) (table 1). This subfamily 
is a paraphyletic grouping comprising ABCF sequences that can not confidently be classified into 
any of the other subgroups (fig. 1). The next most broadly distributed group is Uup (B. subtilis 
protein name YfmR), which itself is paraphyletic to EttA. B. subtilis does not encode EttA, but does 
encode YbiT (B. subtilis name YkpA). It also encodes two ABCFs not present in E. coli: YfmM and 
VmlR (also known as ExpZ). VmlR is in the ARE2 subfamily, and confers resistance to 
virginiamycin M1 and lincomycin [19]. Insertional disruptants of all the chromosomal ABCF genes 
in B subtilis strain 168 have been examined for resistance to a panel of nine MLS class antibiotics, 
and only VmlR showed any hypersensitivity [19]. With the exception of EttA [16, 17], and the 
seven antibiotic resistance ARE ABCFs (table 1), the biological roles of the other 22 bacterial 
ABCFs are largely obscure.  
 
B. subtilis ARE VmlR is a cytoplasmic protein that directly protects the ribosome from antibiotics 
B. subtilis virginiamycin M and lincomycin resistance factor ABCF VmlR was originally annotated as 
an ABC efflux transporter, i.e. a membrane protein [19, 56].  To probe VmlR’s interaction with 
ribosomes in the cell we took advantage of ATPase-deficient VmlR mutants generated by 
simultaneous mutation of both glutamate residues for glutamine (EQ2) [57] that lock ABC enzymes 
in an ATP-bound active conformation [17, 58]. In parallel to the current study, these mutations 
have allowed us to resolve the structure of VmlR on the ribosome [34]. In the case of EttA, 
expression of the EQ2 mutant results in a dominant-negative phenotype as EttA incapable of ATP 
hydrolysis acts as a potent inhibitor of protein synthesis and, consequently, bacterial growth [16]. 
We constructed C-terminally tagged His6-TEV-3xFLAG-tagged (HTF-tagged) wild type and EQ2 
(vmlR-HTF and vmlREQ2-HTF) under the control of an IPTG-inducible Phy-spank promotor [59]. To 
probe the intracellular localization of VmlR, we C-terminally tagged VmlR with the mNeonGreen 
fluorescent protein [60] under the control of xylose inducible promoter protein Pxyl [61]. We have 
validated the functionality of the fusion constructs by lincomycin resistance assays using a ∆vmlR 
knock-out strain as a negative control and a ∆vmlR knock-out strain expressing untagged VmlR 
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under the control of an IPTG-inducible Phy-spank promotor as a positive control (fig. S4A-C). While C-
terminal tagging with either HTF or mNeonGreen does not abolish VmlR’s activity, the EQ2 
versions of the tagged proteins are unable to protect from lincomycin (fig. S4B). 
 
After establishing the functionality of the tagged VmlR constructs, we tested the effects of 
expression of either wild type or EQ2 VmlR-HTF on B. subtilis growth in rich LB media (fig. 4A). 
Expression of the wild type protein in the ∆vmlR background has no detectable effect. In contrast, 
the EQ2 version inhibits growth: while exponential growth is unaffected, the cells enter the 
stationary phase at lower cell densities, abruptly stopping growth instead of slowing down 
gradually (fig. 4A). Two factors are likely to cause the growth-phase specificity of the inhibitory 
effect. First, during the exponential growth cells efficiently dilute the toxic protein via cell division, 
and when the growth slows down, VmlR-EQ2-HTF accumulates. Second, upon entering the early 
stationary phase, B. subtilis sequesters 70S ribosomes into inactive 100S dimers [62], and this 
decrease of active ribosome concentration could conceivably render the cells more vulnerable to 
the inhibitory effects of VmlR-EQ2. We probed the interaction of wild type and EQ2 VmlR-HTF with 
ribosomes using polysome analysis in sucrose gradients in combination with Western blotting (fig. 
4B). While the wild type protein barely enters the gradient (most likely dissociating from the 
ribosomes during centrifugation), the EQ2 version almost exclusively co-localises with the 70S 
peak fraction and is absent from the polysomal fractions (fig. 4B), suggesting co-sedimentation of a 
tight 70S:VmlR-EQ2 complex, and that VmlR-EQ2 is incompatible with actively translating 
ribosomes. 
 
Finally, having ascertained the functionality of VmlR-mNeonGreen (fig. S4C), we imaged B. subtilis 
cells expressing VmlR-mNeonGreen in the presence and absence of lincomycin (fig. 4C) and 
quantified the intensity of the fluorescent signal across the cell (fig. 4D). As a positive control for 
membrane localization we used WALP23-GFP [63] – an artificial model transmembrane helix 
WALP23 [64] fused with an N-terminal GFP label. We observe no evidence for association of VmlR 
with the membrane: the protein is clearly cytoplasmic, with a slight exclusion from the nucleoid in 
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the presence of 5 g/mL lincomycin. A likely explanation for this effect is the nucleoid compaction 
caused by inhibition of translation resulting in protein exclusion from the nucleoid-occupied space 
[65-67]. However, we cannot rule out that this general effect is potentiated by specific interaction 
of VmlR with strongly nucleoid-excluded ribosomes.  
 
E. coli ABCFs EttA, YbiT, YheS and Uup interact genetically and functionally with protein synthesis 
and ribosome assembly 
E. coli encodes four ABCFs: EttA, YbiT, YheS and Uup. An array of structural, biochemical and 
microbiological methods has been used to establish that EttA operates on the ribosome [16, 17]. 
Ribosomal association of the other E. coli ABCFs has not been shown. However, a recent PhD thesis 
by Dr. Katharyn L. Cochrane suggests that Uup interacts genetically with an enigmatic ribosome-
associated factor, the trGTPase BipA (synonym TypA) [68]. The E. coli bipA knock-out strain is 
characterised by a decreased level of 50S subunits accompanied by an accumulation of pre-50S 
particles [69]. In the presence of its native substrate, GTP, BipA associates with mature 70S 
ribosomes [70], occupying the ribosomal A-site [71]. However, in the presence of the stress 
alarmone (p)ppGpp – a molecular mediator of the stringent response [72] – BipA binds the 30S 
subunit [73]. 
 
We have set out to systematically probe the involvement of E. coli ABCFs in protein synthesis. We 
used two experimental systems. The first is geared towards low level constitutive expression of 
native, untagged wild type and EQ2 proteins in a clinically relevant uropathogenic E. coli strain 
CFT073 [74]. For this, we cloned ABCF genes into a low copy pSC101 vector under control of a 
constitutive tet-promoter (Ptet) that in the original plasmid drives expression of the tetracycline 
efflux pump TcR [75]. Using the λRed-mediated gene disruption method [76] we generated a set of 
mutants lacking each of the four ABCF genes, as well as a ∆bipA and ∆bipA∆uup knock-out strains. 
The second system allows inducible high-level expression of tagged proteins in the avirulent 
BW25113 E. coli strain [77, 78]. We used wild type and EQ2 mutants of EttA, YbiT, YheS and Uup 
with N-terminal FLAG-TEV-His6 (FTH)-tags expressed from a low copy pBAD18 plasmid under an 
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arabinose-inducible araBAD (PBAD) promoter. The BW25113 strain can not metabolise arabinose 
(Δ(araD-araB)567 genotype) [77], and therefore the inducer is not metabolised during the 
experiment. 
 
First we tested the genetic interactions between bipA and all E. coli ABCFs in CFT073 background. 
At 37˚C the bipA CFT073 knock-out strain has no growth defect (fig. S5A), however at 18˚C, the 
∆bipA strain displays a pronounced growth defect characteristic of strains defective in ribosome 
assembly (fig. 5A) [79]. Ectopic expression of Uup efficiently suppresses the growth defect, while 
deletion of uup in the bipA background exacerbates it (fig. 5A). Expression of EttA and Ybit have no 
effect, but expression of YheS leads to a dramatic growth defect. Importantly, in the wild type 
background, the expression of YheS has no effect on growth at 18˚C (fig. S5B), indicating that the 
genetic interaction between bipA and yheS is specific. As reported previously, disruption of bipA 
leads to a dramatic ribosome assembly defect at low (18˚C) temperature [69] (fig. 5B). The levels 
of mature 70S ribosomes as well as 50S subunits are dramatically decreased, accompanied by an 
accumulation of 50S assembly precursors (the peak marked with an asterisk) and free 30S 
subunits. Ectopic expression of Uup partially suppresses these defects, and in the ∆bipA∆uup strain 
the defects are exacerbated. All of the effects described above are conditional on disruption of bipA 
since neither disruption of individual ABCF genes nor simultaneous disruption of uup and ettA – 
the only well-characterised ribosome-associated E. coli ABCF to date – causes cold-sensitivity (fig. 
S5C) or affects polysome profiles (fig. S5D). 
 
Next we set out to test the effects of EQ2 versions of ABCFs on translation. We validated the 
expression of the FTH-tagged ABCFs using Western blotting (fig. S6A). As was observed for 
untagged Uup (fig. 5A), the expression of FTH-tagged Uup suppresses the cold sensitivity caused 
by bipA deletion while YheS expression exacerbates the growth defect (fig. S6B-C). Expression of 
the EQ2 versions universally causes growth inhibition, both at 18˚C in ΔbipA CFT073 (fig. S6C) and 
at 37˚C in the wild type BW25113 background (fig. 6). Overexpression of none of the wild type 
ABCFs results in a growth defect (fig. 6A-D). Next we used a 35S-methionine pulse-labeling assay as 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 17 
a readout of translational inhibition. For all the ABCF-EQ2s, the methionine incorporation 
decreases, showing protein synthesis is clearly inhibited. The strongest effect is observed for EttA-
EQ2 (fig. 6A) and YbiT-EQ2 (fig. 6C), and the weakest is seen for Uup-EQ2 (fig. 6B).  
 
Phylogenetic analysis reveals putative AREs 
Through phylogenetic analysis of predicted proteins and previously documented AREs with 
sequences available in UniProt [39] and the Comprehensive Antibiotic Resistance Database (CARD) 
[80], we have identified seven groups of AREs (fig. 1, table 1). Surprisingly, these can be quite 
variable in their subdomain architecture (fig. 7A). Some AREs (ARE1-5) have experienced 
extension of the Linker by on average around 30 amino acids compared to EttA, which is in line 
with the observation that the extended Linkers of ARE1 MsrE and ARE2 VmlR are in close contact 
with the bound antibiotic [33, 34]. However, Linker extension is not the rule for AREs; ARE7 
(OptrA) has a Linker of comparable length to the E. coli ABCFs (fig. 7A). This supports the notion 
based on the VmlR–ribosome co-structure that antibiotic protection by ABCFs involves allosteric 
changes in the ribosome as well as direct protein-drug interaction [34]. The Arm subdomain that in 
EttA interacts with the L1 ribosomal protein and the L1 stalk rRNA (fig. 7A) varies in length among 
AREs, and the CTD extension may or not be present (fig. 7B). Surprisingly, the Uup protein from 
cave bacterium Paenibacillus sp. LC231, a sequence that is unremarkable among Uups (fig. S1), 
confers resistance to the pleuromutilin antibiotic tiamulin when heterologously expressed in E. coli 
[81]. 
 
Actinobacteria are the source of many ribosome-targeting antibiotics [82], and they have evolved 
measures to protect their own ribosomes, including ARE4 (OleB) and ARE5 (VarM). In addition to 
these known AREs, Actinobacteria encode a number of other ABCFs specific to this phylum (AAF1-
6; table 1). It is possible that some – if not all – of these groups are in fact AREs. Other subfamilies 
may also be unidentified AREs, but two particularly strong candidates are BAF2 and BAF3 that 
have strong support for association with ARE5 (fig. 1) and are found in a wide range of bacteria 
(table 1). PAF1 is also worthy of investigation; it is found in the genomes of several pathogens in 
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the proteobacterial genera Vibrio, Enterobacter, Klebsiella, Serratia and Citrobacter, but not 
Escherichia (table S1). With the exception of antibiotic producers, known antibiotic resistance 
ABCFs tend to have a variable presence within genera (fig. S7), probably because they are 
frequently transferred on plasmids and other mobile elements (for example [25, 83, 84]). 
Therefore, variability in the presence of a subfamily across species in a genus can be an indication 
that an ABCF is an ARE. Taking into account phylogenetic relationships (fig. 1, fig. S1) and 
disjunction within genera (fig. S7), we predict the following novel AREs: AAF1-5 (which tend to be 
found in antibiotic producers), BAF1-3, FAF1-2, and PAF1. 
 
ABCFs are polyproline-rich proteins 
Curiously, we find that ABCFs from both bacteria and eukaryotes are often rich in polyproline 
sequences, which are known to cause ribosome slow-down or stalling during translation [85]. This 
stalling is alleviated by the elongation factor EF-P in bacteria [86, 87], and indeed EF-P is required 
for full expression of EttA, which contains two XPPX motifs [88]. 56% of all the sequences in our 
ABCF database contain at least two consecutive prolines, compared to an overall 37% of all the 
proteins in the predicted proteomes considered here. There is a particularly proline-rich hotspot 
in the C-terminal part of the Linker (fig. 7B), which can be up to nine consecutive prolines long in 
the case of Uup from Novosphingobium aromaticivorans (NCBI protein accession number 
WP_028641352.1). Arms and CTD extensions are also polyproline hotspots; PPP is a common 
motif in the Arm of EttA proteins, and polyprolines are frequent in YdiF, Uup and YheS CTD 
extensions. Prolines are rigid amino acids, and conceivably their presence may support the tertiary 
structures of ABCFs, particularly the orientation of the subdomain coiled coils [89].  
 
Discussion 
 
Towards a general model for non-eEF3 ABCF function 
In the case of ABCFs that act on the assembled ribosome during translation, the E-site should be 
vacant (i.e. not filled by an E-site tRNA) for the protein to bind. Specifically, this would be when the 
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E-site has not yet received a tRNA (in the case of 70S initiation complex binding by EttA [16, 17]), 
or when an empty tRNA has dissociated and not been replaced (during slow or stalled translation 
such as in the presence of an antibiotic, as in the case of AREs [33, 34]). EttA has been proposed to 
promote the first peptide bond after initiation through modulation of the PTC conformation [16, 
17]; similarly, allosteric effects acting on the PTC have been observed for the ARE VmlR [34]. This 
structural modulation or stabilisation could conceivably be a general function of ABCFs, with the 
specific ribosomal substrate differing depending on the stage of translation, assembly, or cellular 
conditions. Differences in subdomains would determine both what is sensed and the resulting 
signal. For instance the presence of the Arm would affect signal transmission between the PTC and 
the L1 protein and/or the L1 stalk. 
 
Evolution of AREs 
In order to determine antibiotic resistance capabilities and track the transfer routes of resistance, 
it is critical to be able to annotate antibiotic resistance genes in genomes. This requires 
discrimination of antibiotic genes from homologous genes from which resistance functions have 
evolved. At present this is not straightforward for ARE ABCFs, as the distinction between potential 
translation and antibiotic resistance factors is ambiguous. ARE ABCFs have been compared to the 
Tet family of antibiotic resistance proteins that evolved from trGTPase EF-G to remove tetracycline 
from the ribosome [29]. However the distinction between Tet proteins and EF-G is much more 
clear-cut, with Tet comprising a distinct lineage in the evolutionary history of trGTPases [35]. The 
surprising lack of a clear sequence signature for antibiotic resistance in the ARE ABCFs suggests 
that antibiotic resistance functions may evolve in multiple ways in ABCFs, and that ABCFs closely 
related to AREs may have similar functions to the AREs, while not conferring resistance. For 
example, there are multiple small molecules that bind the PTC and exit tunnel [90], and 
conceivably ABCFs could be involved in sensing such cases, removing the small molecule, or 
allowing translation of a subset of mRNAs to continue in its presence. Even macrolide antibiotics 
that target the exit tunnel do not abrogate protein synthesis entirely, but rather reshape the 
translational landscape [91, 92].  
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Conclusion 
 
ABCFs are stepping into the limelight as important translation, ribosome assembly and antibiotic 
resistance factors. We have found hydrolysis-incompetent EQ2 mutants of all four E. coli ABCFs 
inhibit protein synthesis, suggesting they all function on the ribosome. Overexpression of Uup 
suppresses both the cold-sensitivity and the 50S ribosome assembly defect caused the loss of 
translational GTPase BipA, suggesting that Uup is involved in the 50S ribosome subunit assembly, 
either directly or indirectly, for example by fine-tuning expression of ribosomal proteins. ARE2 
VmlR has joined the ranks of AREs confirmed to act on the ribosome, along with ARE3 LsaA, and 
ARE1s VgaA and MsrE. This, combined with the well-established ribosome association of 
eukaryotic ABCFs, suggests that ribosome binding is a general – perhaps ancestral – feature of 
ABCFs. However, the ABCF family is diverse, and even within subfamilies, there can be differences 
in subdomain architecture. More structures of different ABCFs along with biochemical and 
phenotypic data are required to make sense of how our observed sequence differences translate 
into functional specialisation and molecular mechanisms of the various ABCF subfamilies. We have 
identified clusters of antibiotic resistance ARE ABCFs, and predicted likely new AREs. Strikingly, 
the AREs do not form a clear monophyletic group, meaning that antibiotic resistance-linked 
function has either evolved multiple times independently from the ABCF diversity, or that this is an 
innate ability of ABCFs, raising the possibility of a general role of ABCFs in ribosome-binding small 
molecule sensing and signaling.  
 
Methods 
Sequence searching and classification 
 
Predicted proteomes were downloaded from the NCBI genome FTP site (2nd December 2014). One 
representative was downloaded per species of bacteria (i.e. not every strain). Seven additional 
proteomes were downloaded from JGI (Aplanochytrium kerguelense, Aurantiochytrium limacinum, 
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Fragilariopsis cylindrus, Phytophthora capsici, Phytophthora cinnamomi, Pseudo-nitzschia 
multiseries, and Schizochytrium aggregatum). Previously documented AREs were retrieved from 
UniProt [39] and the Comprehensive Antibiotic Resistance Database (CARD) [80]. Taxonomy was 
retrieved from NCBI, and curated manually where some ranks were not available. 
 
An initial local BlastP search was carried out locally with BLAST+ v 2.2.3 [93] against a proteome 
database limited by taxonomy to one representative per class or (order if there was no information 
on class from the NCBI taxonomy database), using EttA as the query. Subsequent sequence 
searching against the proteome collections used hmmsearch from HMMER 3.1b1, with HMMs 
made from multiple sequence alignments of subfamilies, as identified below. The E value threshold 
for hmmsearch was set to 1e-70, a value at which the subfamily models hit outside of the 
eukaryotic-like or bacterial-like ABCF bipartitions, ensuring complete coverage while not picking 
up sequences outside of the ABCF family.  
 
Sequences were aligned with MAFFT v7.164b (default settings) and Maximum Likelihood 
phylogenetic analyses were carried out with RAxML-HPC v.8 [94] on the CIPRES Science Gateway 
v3 [95] using the LG model of substitution, after removing positions containing >50% gaps. 
Additional phylogenetic analyses of representative sequences were carried out as described in the 
section “phylogenetic analysis of representatives”, below. Trees were visualised with FigTree v. 
1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) and visually inspected to identify putative 
subfamilies that preferably satisfied the criteria of 1) containing mostly orthologues, and 2) had at 
least moderate (>60% bootstrap support). These subfamilies were then isolated, aligned 
separately and used to make HMM models. Models were refined with subsequent rounds of 
searching and classification into subfamilies first by comparisons of the E values of HMM hits, then 
by curating with phylogenetic analysis. After the final classification of all ABCF types in all 
predicted protein sequences using HMMER, some manual correction was still required. For 
example, cyanobacterial sequences always hit the chloroplast HMM with a more significant E value 
than the bacterial model, and eEF3/New1/eEF3L sequences could not be reliably discriminated 
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between using E value comparisons. Therefore, the final classification is a manually curated 
version of that generated from automatic predictions (table S2). All sequence handling was carried 
out with bespoke Python scripts, and data was stored in a MySQL database (exported to Excel files 
for the supplementary material tables). Identification of EFL and eEF1A in predicted proteomes 
was carried out with HMMER, using the HMMs previously published for these trGTPases [35]. The 
E value cut-of was set to e-200, lenient enough to match both eEF1A or EFL, with assignment to 
either protein subfamily made by E value comparisons as above. 
 
Domain prediction 
Domain HMMs were made from subalignments extracted from subfamily alignments. Partial and 
poorly aligned sequences were excluded from the alignments. All significant domain hits (<E value 
1e-3) for each ABCF sequence were stored in the MySQL database. Sequence logos of domains were 
created with Skylign [96]. Putative transit peptides for mitochondrial and plastid subcellular 
localization were predicted with the TargetP web server hosted at the Technical University of 
Denmark [97].  
 
Phylogenetic analysis of representatives 
 
For the representative tree of the ABCF family, taxa were selected from the ABCF database to 
sample broadly across the tree of life, including eukaryotic protistan phyla, while also covering all 
subfamilies of ABCFs. Sequences were aligned with MAFFT with the L-ins-i strategy [98] and 
positions with >50% gaps, and several ambiguously aligned positions at the termini were 
removed. The resulting 249 sequences, and 533 positions were subject to RAxML and IQ-TREE 
Maximum Likelihood phylogenetic analysis, both run on the CIPRES Science Gateway v3 [95]. 
RAxML was run with the LG substitution matrix, as favoured by ProtTest 2.4 [99] and 100 
bootstrap replicates. Bootstrapping with RaxML yields a value (maximum likelihood bootstrap 
percentage, MLB) for how much of the input alignment supports a particular branch in the tree 
topology, and therefore the reliability of that branch. These support values are indicated on 
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branches in the tree figures. In the case of IQ-TREE, the most appropriate model was selected by 
the program during the run, which also favoured the LG substitution matrix. IQ-TREE was run with 
its ultrafast bootstrapping approximation method to ascertain support values (UFB) for branches 
out of 1000 replicates [100]. To test whether our trees made with ABC domains separately are 
incompatible (as might indicate recombination), the RaxML and IQ-TREE analyses were repeated 
with a dataset containing the ABC domains uncoupled from each other and aligned together. 
Alignments were prepared as above, to make a data set of 204 alignment positions from 525 taxa 
(Text S1). 
 
Bayesian inference phylogenetic analysis was carried out with MrBayes v3.2.6, also on the CIPRES 
gateway. The analysis was run for 1 million generations, after which the standard deviation of split 
frequencies (SDSF) was 0.08. The mixed model setting was used for determining the amino acid 
substitution matrix, which converged on WAG. RAxML analysis with the WAG model showed no 
difference in topology for well-supported branches compared to the RAxML tree with the LG 
model. Branch support values in this case are posterior probabilities, shown on the tree figure as 
Bayesian Inference posterior probabilities (BIPP), on a scale of 0 to 1, with increasing probability.  
 
For the rooted tree with ABCE as the outgroup, all ABCFs were selected from A. thaliana, H. sapiens, 
E. coli, B. subtilis, S. cerevisae, S. pombe, along with ABCE from these organisms and Methanococcus 
maripaludis. Ambiguously aligned sites were identified and removed manually. RAxML, IQ-TREE 
and MrBayes were carried out as above on the resulting 344 positions from 35 sequences. The 
MrBayes analysis stopped automatically when the SDSF dropped to the 0.009 threshold, which was 
at 235,000 generations.  
 
For the tree of eukaryotic and viral ABCFs rooted with YheS, sequences were extracted from the 
ABCF database, and viral sequences were found in the NCBI protein database using BlastP. The 
resulting 658 sequences were aligned with MAFFT and a RAxML analysis of 645 positions was 
carried out as above. The alignments used to build the phylogenies presented in the main text as 
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supplementary information are available in text S1, along with trees that are used for ascertaining 
branch support but not included as figures. 
 
Structural analyses 
Homology modeling was carried out using Swiss Model [101] with EttA (PDB ID 3J5S) as the 
template structure. Because the Linkers were lacking secondary structure, QUARK [102] was used 
for ab initio structure modeling of these regions, and the resulting coils were aligned back to the 
homology model using the structural alignment method of MacPyMOL [103]. The presence of 
coiled coil regions was predicted with the COILS program hosted at the ExPASy Bioinformatics 
Research Portal [104]. 
 
Construction of plasmids and bacterial strains 
All bacterial strains and plasmids used in this study are described in Supplementary Methods 
and listed in Table 2. 
 
Growth assays 
Bacterial growth (OD600) was monitored using a Bioscreen C (Oy Growth Curves Ab Ltd) 
microplate reader in Honeycomb plates (150 µL culture per well) with continuous shaking (speed: 
fast, amplitude: normal). All experiments with CFT073 were performed at 18C unless stated 
otherwise. Three biological replicates were averaged for each growth curve and the data presented 
as geometric means ± standard deviation. 
 
E. coli transformed with pSC101-based expression plasmids:  
Overnight (16 h) cultures were pre-grown in LB medium supplemented with 50 g/mL 
kanamycin, diluted to OD600 of 0.03 in filtered LB and grown in Bioscreen C microplate reader as 
described above.  
 
E. coli transformed with pBAD-based expression plasmids:  
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Overnight (16 h) cultures were pre-grown in Neidhardt MOPS medium [105] supplemented with 
0.1% of casamino acids, 0.4% glucose as a carbon source and 100 g/mL carbenicillin, diluted to 
OD600 of 0.03 in the same media but containing and 0.5% glycerol instead of 0.4% glucose as well 
as supplemented with 0.5% arabinose and grown in Bioscreen C microplate reader as described 
above.  
 
Antibiotic resistance testing of tagged B. subtilis VmlR:  
B. subtilis strains VHB38, VHB91 and VHB92 were pre-grown on LB plates overnight at 30˚C. Fresh 
individual colonies were used to inoculate filtered LB medium, either in the presence and absence 
of 1 mM IPTG (for VHB91 and VHB92) or in the presence and absence of 0.3% xylose (for VHB38), 
and OD600 adjusted to 0.01. The cultures were seeded on Honeycomb plates, and plates incubated 
in a Bioscreen C at 37 °C with continuous shaking as described above for E. coli cultures. After 90 
minute incubation (OD600  0.1) increasing concentrations of lincomycin (final concentration 0 - 5 
μg/ml) were added and growth was monitored for additional 6 hours. Three biological replicates 
were averaged for each growth curve and the data presented as geometric means ± standard 
deviation. 
 
Fluorescence microscopy 
Fluorescence microscopy was carried out with cell grown to early-mid logarithmic growth phase 
(OD600 of 0.2-0.5) in LB medium at 37 °C in the presence or absence of inducers. The used inducer 
concentrations were 0.3% for VmlR-mNG and 1% for WALP23-GFP. If indicated, the cells were 
incubated with 5µg/ml lincomycin upon shaking at 37 °C prior to the microscopy. The cells were 
immobilised on microscopy slides covered with a thin film of 1.2% (w/v) agarose in H2O as 
described in detail elsewhere [106]. The microscopy was carried out with Nikon Eclipse Ti 
equipped with Nikon Plan Apo 100x/1.40 Oil Ph3 objective, Sutter Instrument Company Lambda 
LS xenon arc light source, and Photometrics Prime sCMOS camera. The images were captured 
using Metamorph 7.7 (Molecular Devices) and analysed using Fiji [107]. 
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Western blot analysis of FTH-tagged wt and EQ2 E. coli ABCF proteins 
Preparation of bacterial samples:  
Bacteria were grown either at 37 C (E. coli BW25113 derivatives) or 18C (E. coli ΔbipA CFT073 
derivatives) up to OD600 of 0.5 in 50 mL of Neidhardt MOPS minimal medium [105] supplemented 
with 0.1% casamino acids (w/v), 0.5% glycerol (w/v) and 100 µg/mL carbenicillin and L-
arabinose was added to a final concentration of 0.2% (w/v). Cultures grown at 37C were 
harvested 10 minutes after induction by pouring them into precooled centrifuge bottles containing 
100 g of crushed ice and centrifuged at 10,000 rpm for 10 minutes at 4 °C (Beckman JLA16.250 
rotor). Cultures grown at 18C were harvested 5 hours after induction by collecting into precooled 
centrifuge bottles and pelleting at 10,000 rpm for 10 minutes at 4 °C (Beckman JA25.50 rotor). 
Lysates were prepared the same as for polysome profiling of E. coli (see below).  
Western blotting:  
3 g of total protein as determined by Bradford assay of each sample was resolved on 10% SDS-
PAGE gel and transferred to 0.2 m nitrocellulose membrane (Trans-Blot Turbo Transfer Pack, 
Bio-Rad) using Turbo MIXED MW protocol in Trans-Blot Turbo Transfer System (Bio-Rad). The 
membrane was blocked in PBS-T (1x PBS 0.05% Tween-20) with 5% w/v nonfat dry milk at room 
temperature for one hour. Antibody incubations were performed for one hour in 1% nonfat dry 
milk in PBS-T with five 5-minute washes in fresh PBS-T between and after antibody incubations. 
FTH-tagged ABCFs were detected using anti-Flag M2 primary (Sigma-Aldrich, F1804; 1:10,000 
dilution) antibodies combined with anti-mouse-HRP secondary (Rockland; 610-103-040; 1:10,000 
dilution) antibodies. AECL detection was performed on ImageQuant LAS 4000 (GE Healthcare) 
imaging system using Pierce ECL Western blotting substrate (Thermo Scientific). 
 
Polysome profiling analysis of E. coli strains 
Preparation of bacterial samples:  
Overnight (16 h) cultures were pre-grown at 37C in LB medium supplemented with 50 g/mL 
kanamycin in the case of strains transformed with pSC101-based expression plasmids. Overnight 
cultures were diluted in filtered LB (33 mL cultures) and after 24 h growth at 18 C harvested by 
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pouring into precooled centrifuge bottles and pelleting at 10,000 rpm for 10 minutes at 4 °C 
(Beckman JA25.50 rotor). For the sake of convenience, cultures were diluted to different starting 
densities (Table S3) to ensure that all of them reach OD600 ≈0.5 simultaneously.  
Preparation of clarified lysates:  
Cell pellets were resuspended in 0.4 mL of Polymix buffer [108] (20 mM HEPES:KOH pH 7.5, 95 
mM KCl, 5 mM NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 mM spermidine, 1 mM 
DTT) and 200 µL of pre-chilled zirconium beads (0.1 mm) were added to each sample. Cellular 
lysates were prepared by a FastPrep homogeniser (MP Biomedicals) (three 20 seconds pulses at 
speed 6.0 mp/sec with chilling on ice for 1 minutes between the cycles) and clarified by 
centrifugation at 21,000 g for 10 minutes at 4 °C. The supernatant was carefully collected avoiding 
the lipid layer and cellular pellet, aliquoted, frozen in liquid nitrogen and stored at -80 °C until 
further processing.  
Sucrose gradient centrifugation:  
After melting the frozen samples on ice, 2 A260 units of each extract was loaded onto 5–25% (w/v) 
sucrose density gradients in Polymix buffer, 5 mM Mg2+ [108]. Gradients were resolved at 35,000 
rpm for 2.5 hours at 4 °C in SW41 rotor (Beckman) and analysed using Biocomp Gradient Station 
(BioComp Instruments) with A260 as a readout. The ribosome profiles presented were normalised 
to the total area under the curve and are representative of at least three independent experiments 
for each strain.  
 
Polysome profiling and Western blot analysis of B. subtilis strains 
Experiments were performed as described above for E. coli strains, with minor modifications.  
Preparation of bacterial samples and preparation of clarified lysates:  
VHB90 and VHB91 strains were pre-grown on LB plates overnight at 30 °C. Fresh individual 
colonies were used to inoculate 200 mL LB cultures. The cultures were grown at 37 C until OD600 
of 0.3 and IPTG was added to final concentration of 30 μM. After 30 min cells were collected by 
centrifugation (8,000 rmp, 10 minutes), dissolved in 0.5 mL of Polymix buffer [108] (20 mM 
HEPES:KOH pH 7.5, 95 mM KCl, 5 mM NH4Cl, 10 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 
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mM spermidine, 1 mM DTT,  2 mM PMSF), lysed (FastPrep homogeniser (MP Biomedicals): four 20 
seconds pulses at speed 6.0 mp/sec with chilling on ice for 1 minutes between the cycles), and 
clarified by ultracentrifugation (14,800 rpm, 20 minutes). 
Sucrose gradient centrifugation and Western blotting:  
Clarified cell lysates were loaded onto 7–35% sucrose gradients in Polymix buffer [108] (20 mM 
HEPES:KOH pH 7.5, 95 mM KCl, 5 mM NH4Cl, 10 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 
mM spermidine, 1 mM DTT) and subjected to centrifugation (35,000 rpm for 3 hours at 4 °C). C-
terminally HTF-tagged VmlR (wild type and EQ2 mutant) and ribosomal protein L3 of the 50S 
ribosomal subunit were detected using either anti-Flag M2 primary combined with anti-mouse-
HRP secondary antibodies or anti-L3 primary (a gift from Fujio Kawamura) combined with goat 
anti-rabbit IgG-HRP secondary antibodies, respectively. All antibodies were used at 1:10,000 
dilution. 
 
L-[35S]-methionine pulse-labelling 
Preparation of bacterial samples:  
Since glucose specifically inhibits the arabinose promoter, the cultures were grown in defined 
Neidhardt MOPS medium [105] supplemented with 0.4% glycerol as a carbon source. One colony 
of freshly transformed E. coli BW25113 cells expressing N-terminal FTH-tagged ABCFs (wild type 
and EQ2 mutants) from pBad vector was used to inoculate 10 mL of 1x MOPS media supplemented 
with 0.4% glycerol 100 g/mL carbenicillin, and the cultures were grown until early stationary 
phase (about 24 hours). Stationary phase cells were diluted to OD600 of 0.04–0.07 in 25 mL of the 
same media, grown at 37 °C with vigorous shaking (200 rpm) to OD600 of 0.15–0.2 and expression 
of ABCFs was induced by addition of L-arabinose to the final concentration of 0.2%.  
L-[35S]-methionine pulse-labelling:  
For radioactive pulse labelling, 1 μCi L-[35S]-methionine (500 μCi, PerkinElmer) aliquots were 
prepared in 1.5 mL Eppendorf tubes. The specific activity of the radioactive methionine solution 
from PerkinElmer, was 1175 Ci/mmol, and the working mix of ‘hot’ and ‘cold’ methionine with a 
final concentration of 15 mM had a specific activity of 205 mCi/mmol. As a zero time point, 1 mL of 
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cell culture was taken and mixed with an aliquot of radioactive methionine just before inducing 
cells with L-arabinose. Simultaneously a 1 mL aliquot was taken for an OD600 measurement. All 
consecutive samples were processed similarly at designated time points after induction. 35S-
methionine incorporation was stopped after 5 minutes by chloramphenicol added to the final 
concentration of 200 µg/mL. Subsequent processing of samples differs in the case of scintillation 
counting and autoradiography.  
Scintillation counting:  
1 mL of culture was combined with 200 µL of 50% trichloroacetic acid (TCA), passed through a 
GF/C filter (Whatman) prewashed with 5% TCA and unincorporated label was removed by 
washing the filter with 5 mL of ice-cold 5% TCA followed by 5 mL of ice-cold 95% EtOH [109]. 
Filters were dried for at least 2 hours, and counted on a TRI-CARB 4910TR 110 V scintillation 
counter (PerkinElmer) (5 mL of ScintiSafe 3 scintillation cocktail (FisherScientific) per sample, 
pre-soaked with shaking for 15 minutes prior to counting).  
Autoradiography:  
1 mL cultures were pelleted by centrifugation, cell pellet washed with Phosphate Buffered Saline 
(PBS) to remove unincorporated L-[35S]-methionine and dissolved/lysed in 50 μL 1x SDS-loading 
buffer. Samples were normalised by OD600 by addition of appropriate volume of 1x SDS-loading 
buffer (50-80 µL according to OD600), and 10 µL of the sample was loaded onto 10% SDS-PAGE 
and resolved electrophoretically (BioRad), gels were dried on Whatman paper, exposed on BAS 
storage phosphor screen (GE Heathcare) overnight, and scanned by Typhoon imaging system (GE 
Heathcare).  
 
Accession numbers 
NCBI protein: YP_009052194.1; NCBI protein: XP_008030281.1; NCBI protein: XP_007703000.1; 
NCBI protein: XP_007692076.1; NCBI protein: XP_003306113.1; NCBI protein: WP_028641352.1; 
NCBI conserved domains database: cl11104 
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Centre for Microbial Research (UCMR) gender policy programme (GCA); Carl Tryggers grants CTS 
14:34 & CTS 15:35 (GCA); Kempe Stiftelse grant JCK-1627 (GCA); Jeanssons Stiftelse grant (GCA); 
Molecular Infection Medicine Sweden (MIMS) (VH); postdoctoral grant from Umeå Centre for 
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Supplementary file captions 
 
S1 Table. Taxonomy of 4505 species, and their ABCF composition  
All species considered in the analysis are listed, ordered by taxonomy. The number and identity of 
ABCF subfamilies are recorded.  
 
S2 Table. Classification of 16848 ABCF sequences into subfamilies, accompanied by domain 
assignments 
The unique sequence identifiers are included for retrieval of data from online repositories. 
 
S3 Table. Domain coordinates 
The domain coordinates for the representative sequences in fig. 3A are listed. In the second tab, all 
the coordinates for each identified domain in all ABCFs are given. As these are from HMM hits, the 
same domain can have more than one hit in each protein. For example, the ABC1 HMM always hits 
the ABC2 domain, and vice versa. Duplicate domain hits were removed when generating fig 3A.  
 
S4 Table. Presence and absence of EFL, eEF1A and eEF3 in eukaryotes 
Where the distribution is unchanged within a specific taxonomic lineage, those rows are collapsed 
down to one, and the highest common taxonomic rank is given. The full lineage data is available in 
the second tab. 
 
S5 Table. Transit peptide predictions 
Predictions were made separately for plastid-containing and non-plastid containing eukaryotes. 
The description of the output format is shown below the predictions.  
 
Table S6. Primers used in the study 
 
Table S7. The starting OD600 of E. coli CFT073 and its derivatives 
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S1 Figure. Ladderised version of the Figure 1 tree 
All branch support values and taxon names including subfamily identity are shown. Branch 
colouring is as per Figure 1. Orange stars show Uup sequences that have truncated Arm 
subdomains. 
 
S2 Figure. Sequence logos of domains show amino acid biases 
Sequence logos of each domain HMM. The height of stacked amino acids at each position show the 
information content, in bits, with letters dividing the height according to their estimated 
probability. Beneath the stacked amino acids there are three lines showing probabilities; line 1 is 
occupancy, the probability of observing a letter – rather than a gap – at that position. Line 2 is the 
probably of seeing an insertion at that position, and line 3 is the expected length of an insertion 
following that position. 
 
S4 Figure. Functional testing of inducible B. subtilis VmlR-HTF and VmlR-NeonGreen fusion 
proteins 
 All experiments were performed in filtered LB at 37˚C in the presence of increasing concentrations 
of lincomycin and presented as the geometric mean ± standard deviation (n = 3). HTF stands for C-
terminal His6-TEV- 3xFLAG tag. 
 
S5 Figure. Growth and polysome analysis of E. coli CFT073 wild type, bipA, abcf and 
bipAuup strains, and E. coli CFT073 wild type overexpressing ABCFs under the control of 
constitutive Ptet promoter 
 All experiments were performed in filtered LB at either 18˚C (A) or 37˚C (B-D) and growth data 
are presented as geometric means ± standard deviation (n = 3). 
 
S6 Figure. Functional testing of FTH-tagged E. coli ABCF wild type and EQ2 proteins 
Western blot (A) and growth assays (B and C) N-terminally FTH-tagged E. coli ABCF proteins 
expressed under the control of arabinose-inducible PBAD promoter. Growth experiments were 
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performed in MOPS media at 18˚C and presented as geometric means ± standard deviation (n = 3). 
Western blotting was performed either at 18˚C or 37˚C. FTH stands for N-terminal 3xFLAG-TEV-
His6 tag. 
 
S7 Figure. AREs show variability in presence across species of the same genus, which can be 
used to predict novel ARE ABCFs  
Genera were selected that contained more than 20 species in the ABCF database. For each 
subfamily in each of those genera, the percent of species in which that subfamily is found, is 
plotted. Colder colours are those ABCFs that are more universal, as typical of housekeeping genes. 
AREs on the other hand have a more patchy distribution, as shown by their tendencies for warmer 
colours. Antibiotic producing genera are the exception, where AREs and ARE-like subfamilies can 
be universal within a genus. 
 
S3 Figure. Maximum likelihood phylogeny of eukaryotic subgroup-type ABCFs from 
eukaryotes and viruses 
The tree is rooted with bacterial YheS sequences. Branch support is from 100 bootstrap replicates 
and branch length is proportional to the number of amino acid substitutions (see lower scale bar). 
Names are coloured by subfamily. 
 
S1 Text. Supplementary sequence alignments and phylogenetic trees 
The file contains sequence alignments used to generate Figures 1 (and S1), 2 and S3 in FASTA 
format, and Newick format phylogenetic trees that are not shown as figures. Each entity 
(alignment  or tree) is separated by comments preceded by “#”. 
 
S1 Materials and Methods. 
Supplementary methods describing the construction of plasmids and bacterial strains 
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Figure legends 
 
Fig. 1 | The family tree of ABCFs has a bipartite structure corresponding to eukaryotic-like 
and bacterial (and organellar)-like sequences 
The tree is a RaxML maximum likelihood phylogeny of representatives across the ABCF family with 
branch support values from 100 bootstrap replicates with RaxML (MLB), 1000 ultrafast bootstrap 
replicates with IQ-TREE (UFB) and Bayesian inference posterior probability (BIPP). The inset box 
shows the legend for subfamily and intersubfamily support; support values within subfamilies and 
that are less that 60% MLB are not shown. Species were chosen that sample broadly across the 
tree of ABCF-encoding life, sampling at least one representative from each subfamily. Green 
shading shows the eukaryotic type ABCFs; other subgroups are bacterial unless marked with a 
green shaded circle to indicate eukaryotic groups with potentially endosymbiotic origin. CpYdif 
contains both cyanobacterial and predicted chloroplast sequences. The full tree with taxon names 
and sequence IDs is shown in fig. S1. Branch lengths are proportional to amino acid substitutions 
as per the scale bar in the lower right. The asterisked branch is not supported by this data set, 
however it is supported at 85% MLB in phylogenetic analysis of the eukaryotic subgroup and its 
viral relatives, rooted with YheS (fig. S3). Branch lengths are proportional to amino acid 
substitutions as per the lower right scale bar. 
 
Fig. 2 | Rooting with ABCE shows eukaryotic-like ABCFs nesting within bacterial-like ABCFs, 
with YheS as the sister group to the eukaryotic-like clade 
Maximum likelihood phylogeny of representatives across the ABCF family, and ABCE sequences 
from the UniProt database. Branch support from 200 bootstrap replicates with RaxML (MBP), 
1000 ultrafast bootstrap replicates with IQ-TREE and Bayesian inference posterior probability is 
indicated with the key in the inset box. Branch lengths are proportional to amino acid substitutions 
as per the inset scale bar. 
 
Fig. 3 | Typical domain and subdomain architectures of ABCFs  
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(A) Boxes show domains as predicted by HMMs. Full coordinates and sequence data for these 
examples are recorded in Table S3. Dotted lines shows possible interactions between the HEAT 
domain of eEF3/New1/eEF3L and the N-terminal domain of ABCF3, ABCF4 and ABCF7.  (B) 
Predicted coiled coil regions of E. coli YheS along the protein length. Inset: cartoon representation 
of the coiled coil subdomains protruding from the core ABC domains. 
 
Fig. 4 | B. subtilis ARE VmlR is a cytoplasmic protein that directly protects the ribosome from 
antibiotics 
(A) Growth of wild type B. subtilis 168, isogenic vmlR knockout as well as vmlR knockout 
expressing either wild type or EQ2 version of VmlR under the control of IPTG-inducible Phy-spank 
promoter. Six biological replicates were averaged for each growth curve and the data presented as 
geometric means ± standard deviation. (B) Polysome analysis and western blotting of vmlR B. 
subtilis expressing C-terminally HTF-tagged wild type and EQ2 version of VmlR. (C) Phase contrast 
and fluorescence images of uninhibited B. subtilis cells expressing VmlR-mNeonGreen (VmlR-mNG) 
in the presence and absence of lincomycin (40 min incubation with 5 µg/ml), and a model 
transmembrane protein WALP23-GFP are shown for comparison. (D) Fluorescence intensity 
profiles were measured perpendicular to the cell length axis along a 325 nm wide and 5.8 µm long 
line as indicated. Fluorescence intensity profiles of cells expressing WALP23-GFP [63], and cells 
expressing VmlR-mNG in the presence and absence of lincomycin. The graph depicts the average 
fluorescence intensity profiles and the corresponding standard deviations (n = 30).  
 
Fig. 5 | Overexpression of E. coli ABCF Uup suppresses cold sensitivity and ribosome 
assembly defects caused by loss of translational GTPase BipA 
Growth (A) and sucrose gradient polysome analysis (B) of CFT073 wild type, isogenic bipA and 
bipAuup, as well as CFT073 bipA transformed with low-copy pSC vector expressing either BipA 
or ABCFs EttA, Uup, UheS and YbiT under control of constitutive promoter Ptet. All experiments 
were performed in filtered LB at 18˚C and data are presented as geometric means ± standard 
deviation (n = 3). 
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Fig. 6 | Expression of E. coli ABCF-EQ2 mutants inhibits growth and protein synthesis 
Growth of wildtype E. coli BW2513 transformed with pBAD18 vector (grey trace) as well as E. coli 
BW2513 expressing either wild type (black trace) or EQ2 mutants (red trace) of EttA (A), Uup (B), 
YbiT (C), and YheS (D) under the control of arabinose-inducible promoter PBAD. Radiographs show 
the effect of wild type and EQ2 ABCF expression on protein synthesis, as probed by pulse labeling 
with L-[35S]-methionine. Expression was induced by the addition of L-arabinose to a final 
concentration of 0.2% at time point 0, and efficiency of incorporation was quantified by 
scintillation counting and visualised by autoradiography at 0 and 20-minute time points. 
Scintillation counting data are presented as geometric means ± standard deviation (n = 3). All 
experiments were performed at 37˚C in Neidhardt MOPS medium [105] supplemented with 0.4% 
glycerol as a carbon source. The inset cartoons are a representation of ABCF domains and sub-
domains, as per the legend in the lower box. 
 
Fig. 7 | AREs tend to have relatively long linker regions that potentially extend towards the 
ribosome bound antibiotics 
(A) The structure of EttA and its interacting ribosomal components from PDB 3J5S [17] is shown 
alongside homology models of S. aureus VgaA and E. faecalis LsaA, using 3J5S as the template, with 
de novo modeling of the linker regions. The dotted circle shows the relative location of PTC-
inhibiting antibiotics. Arm and linker regions are shaded in yellow and turquoise respectively. (B) 
Extracts from the multiple sequence alignment of E. coli and B. subtilis ABCFs, and representative 
AREs, containing the Arm (yellow shading) and Linker (turquoise shading) subdomains. Alignment 
numbering is according to the EttA sequence. A boxed region shows a region that is particularly 
rich in proline and polyproline in various ABCF family members. 
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Table 1 | The subfamilies of the ABCF family, and the numbers (N) of phyla and 
species in which they are encoded 
Subfamily N Phyla N Species Notes on function, relationships and taxonomic distribution 
YdiF 42 1852 Broad distribution in bacteria; polyphyletic 
Uup a 24 3104 Broad distribution in bacteria; paraphyletic to EttA. Inc. P resistance TaeA [39] 
EttA 18 2337 Broad distribution in bacteria; translation factor 
YbiT 15 1874 Broad distribution in bacteria; potential translation factor 
BAF2 7 305 
Proteobacteria, Planctomycetes, Spirochaetes, Actinobacteria, 
Bacteroidetes, Gemmatimonadetes, Cyanobacteria 
ARE1a 6 269 
M,L,S,P,K resistance, inc. VgaA [21], MsrA [18], MsrE [33]; Firmicutes, 
Actinobacteria, Spirochaetes, Bacteroidetes, Proteobacteria, Tenericutes 
ARE3a 5 261 
L resistance inc LsaA [20]; Firmicutes, Spirochaetes, Proteobacteria, 
Fusobacteria, Actinobacteria 
DAF1 5 58 Spirochaetes, Proteobacteria, Deferribacteres, Fibrobacteres, Chlamydiae 
YfmM 5 587 Firmicutes, Tenericutes, Proteobacteria, Fusobacteria, Bacteroidetes 
YheS 5 1234 Proteobacteria, Bacteroidetes, Cyanobacteria, Arthropoda, Elusimicrobia 
BAF3 4 111 Bacteroidetes, Proteobacteria, Cyanobacteria, Elusimicrobia 
DAF2 4 24 Proteobacteria, Planctomycetes, Spirochaetes, Omnitrophica 
ARE2a 2 54 Antibiotic resistance inc. VmlR[19]; Firmicutes, Tenericutes 
ARE4a 2 173 
M,M16 resistance inc. CarA [40], SrmB [40], TlrC [40], OleB[23]; Actinobacteria, 
Chloroflexi 
ARE5a 2 408 L,S resistance inc. VarM [26], LmrC [41]; Actinobacteria, Proteobacteria 
BAF1 2 20 Firmicutes, Actinobacteria 
PAF1 1 138 Proteobacteria 
AAF1 1 313 Actinobacteria 
AAF2 1 301 Actinobacteria 
AAF4 1 219 Actinobacteria 
AAF6 1 649 Actinobacteria 
AAF3 1 8 Actinobacteria 
AAF5 1 25 Actinobacteria 
ARE6a 1 8 L,S resistance SalA [22]; Firmicutes 
ARE7a 1 35 Oxazolidinone resistance OptrA [25], Firmicutes 
BdAF1 1 176 Bacteroidetes 
DAF3 1 36 Proteobacteria 
FAF1 1 37 Firmicutes 
FAF2 1 42 Firmicutes 
SAF1 1 66 Firmicutes 
ABCF2 27 560 
Arb1 ribosome biogenesis factor; broadly distributed but lacking in 
Apicomplexa and Microsporidia 
ABCF1 23 376 
ABC50 translation initiation factor; found in plants, diverse algae, and 
opisthokonts excluding fungi 
ABCF7 16 131 Found in plants, diverse algae, Alveolata, Excavata and Microsporidia 
ABCF3 13 382 Gcn20 starvation response; Opisthokonts 
eEF3L 9 83 Diverse algae, Chytridiomycota and choanoflagellates 
ABCF4 7 37 Diverse algae and Filozoa 
ABCF5 7 105 Diverse algae and fungi 
cpYdiF 7 85 Diverse algae 
algAF1 6 25 Diverse algae 
cpEttA 6 18 Chloroplast targeting peptides predicted; plants and diverse algae 
algUup 5 17 Found in diverse algae 
ABCF6 5 17 Found in diverse algae and Amoebozoa 
mEttA 3 14 mitochondrial targeting peptides predicted; diverse algae, Amoebozoa 
New1 3 127 Fungi 
eEF3 2 138 Translation factor; fungi 
Notes -  a Subfamilies containing known AREs; resistance to antibiotic class in notes column is as follows: M, 14- 
and 15-membered ring macrolides; M16, 16-membered ring macrolides; L, lincosamides; S, streptogramins; K, 
ketolides; P, pleuromutilins  
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Table 2. Strains and plasmids used in the study. 
Strain or Plasmid Description Reference 
Strains: E.coli   
BW BW25113 E. coli [80] 
CFT073 Uropathogenic E. coli O6:K2H1 [77] 
CFTuup Δuup (locus tag c1085) This study 
CFTettA ΔyjjK (locus tag c5478) This study 
CFTyheS ΔyheS (locus tag c4127) This study 
CFTybiT ΔybiT (locus tag c0906) This study 
CFTbipA ΔyihK (locus tag c4820) This study 
CFTbipA_pUup ΔyihK with pSC-uup This study 
Strains: B. subtilis   
B. subtilis 168 trpC2 [107] 
VHB5 trpC2 ΔvmlR This study 
VHB38 trpC2 ΔvmlR amyE::Pxyl-vmlR-
mNeoGreen Spcr 
This study 
VHB44 trpC2 ΔvmlR thrC::Phy-spnak-vmlR Kanr This study 
VHB45 trpC2 ΔvmlR thrC::Phy-spnak-vmlREQ2 
Kanr 
This study 
VHB91 trpC2 ΔvmlR thrC::Phy-spnak-vmlR-HTF 
Kanr 
This study 
VHB92 trpC2 ΔvmlR thrC::Phy-spnak-vmlREQ2-HTF 
Kanr 
This study 
HS64 trpC2 amyE::Pxyl-WALP23-gfp Spcr [66] 
Plasmids   
pKD4 λRed PCR template plasmid with Kan 
resistance cassette; Kanr Ampr 
[79] 
pKD13 λRed PCR template plasmid with Kan 
resistance cassette; Kanr Ampr 
[79] 
pKD46 λRed recombinase helper plasmid, 
temperature sensitive; Ampr 
[79] 
pCP20 FLP recombinase encoding plasmid, 
temperature sensitive; Ampr 
[79] 
pSC101 pSC101 empty vector; Kanr This study 
pSC-ettA Constitutive ettA overexpression 
plasmid; Kanr 
This study 
pSC-uup Constitutive uup overexpression 
plasmid; Kanr 
This study 
pSC-yheS Constitutive yheS overexpression 
plasmid; Kanr 
This study 
pSC-ybiT Constitutive ybiT overexpression 
plasmid; Kanr 
This study 
pSC-bipA Constitutive bipA overexpression 
plasmid; Kanr 
This study 
pHT009 Integration plasmid ;  Kanr AmprKanr This study 
pSG1154 Integration plasmid; Spcr Ampr [64] 
pSHP2 Integration plasmid; Spcr Ampr This study 
VHp62 pAPNC with vmlR-HTF in SalI/BamHI 
sites; Spcr Ampr 
Laboratory stock 
VHp66 pAPNC with vmlREQ2-HTF in 
SalI/BamHI  sites; Spcr Ampr 
Laboratory stock 
pHT009-vmlR pHT009 with  vmlREQ2; Kanr Ampr This study 
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pHT009-vmlR-HTF pHT009 with vmlR-HTF in 
HindIII/SphI site; Kanr Ampr 
This study 
pHT009-vmlREQ2-
HTF 
pHT009 with vmlREQ2-HTF in 
HindIII/SphI site; Kanr Ampr 
This study 
pSHP2-vmlR pSHP2 with vmlR in ApaI/EcoRI site ;  
Spcr Ampr 
This study 
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Research Highlights 
 
 
We present a comprehensive classification of known and novel ABCFs across all life 
 
We predict multiple novel subfamilies of antibiotic resistance ABCFs in pathogens 
 
ATPase deficient mutants of the four Escherichia coli ABCFs disrupt protein synthesis 
 
Two E. coli ABCFs interact genetically with the ribosome assembly GTPase BipA  
 
ARE ABCF VmlR is localised to the cytoplasm, ruling out a role in antibiotic efflux 
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